Alert: Bought 20,000 shares of APPA in Established Portfolio at $1.60. Trading well on a down market day like investors are confident in the company. No current outstanding issues w/the FDA regarding the approval process with this drug. This company has FDA forward-looking event play w/ PDUFA date on March 18th.